{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Double-blind+Abatacept&page=2", "query": { "intervention": "Double-blind Abatacept", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 41, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Double-blind+Abatacept&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Double-blind+Abatacept&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-03T01:26:50.873Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06126042", "title": "Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Test Product", "type": "DRUG" }, { "name": "Reference product", "type": "DRUG" }, { "name": "Reference Medicinal Product", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dr. Reddy's Laboratories Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "MALE", "summary": "18 Years to 50 Years · Male only" }, "enrollment_count": 330, "start_date": "2023-10-03", "completion_date": "2024-07", "has_results": false, "last_update_posted_date": "2023-11-13", "last_synced_at": "2026-10-03T01:26:50.873Z", "location_count": 3, "location_summary": "Lenexa, Kansas • San Antonio, Texas • Salt Lake City, Utah", "locations": [ { "city": "Lenexa", "state": "Kansas" }, { "city": "San Antonio", "state": "Texas" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT06126042" }, { "nct_id": "NCT01860976", "title": "Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Abatacept", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 489, "start_date": "2013-06-17", "completion_date": "2020-06-30", "has_results": true, "last_update_posted_date": "2022-04-05", "last_synced_at": "2026-10-03T01:26:50.873Z", "location_count": 17, "location_summary": "Phoenix, Arizona • Colorado Springs, Colorado • Bridgeport, Connecticut + 14 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Bridgeport", "state": "Connecticut" }, { "city": "Trumbull", "state": "Connecticut" }, { "city": "Sarasota", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01860976" }, { "nct_id": "NCT01350804", "title": "Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "AIN457", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Abatacept", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 551, "start_date": "2011-09", "completion_date": "2015-02", "has_results": true, "last_update_posted_date": "2016-05-23", "last_synced_at": "2026-10-03T01:26:50.873Z", "location_count": 44, "location_summary": "Anniston, Alabama • Vestavia Hills, Alabama • Freemont, California + 40 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Vestavia Hills", "state": "Alabama" }, { "city": "Freemont", "state": "California" }, { "city": "Pomona", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01350804" }, { "nct_id": "NCT00162266", "title": "Abatacept With Methotrexate- Phase IIB", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Abatacept (BMS-188667)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 524, "start_date": "2000-10", "completion_date": "2009-09", "has_results": true, "last_update_posted_date": "2012-06-01", "last_synced_at": "2026-10-03T01:26:50.873Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Long Beach, California + 23 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Long Beach", "state": "California" }, { "city": "Highlands Ranch", "state": "Colorado" }, { "city": "Largo", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00162266" }, { "nct_id": "NCT02504268", "title": "Effects of Abatacept in Patients With Early Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Abatacept", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Abatacept Placebo", "type": "OTHER" }, { "name": "Methotrexate Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 994, "start_date": "2015-09-03", "completion_date": "2020-03-19", "has_results": true, "last_update_posted_date": "2021-06-28", "last_synced_at": "2026-10-03T01:26:50.873Z", "location_count": 42, "location_summary": "Huntsville, Alabama • Glendale, Arizona • Mesa, Arizona + 36 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02504268" }, { "nct_id": "NCT04474847", "title": "Abatacept for the Treatment of Giant Cell Arteritis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Giant Cell Arteritis" ], "interventions": [ { "name": "Abatacept", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 78, "start_date": "2021-03-29", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-10-03T01:26:50.873Z", "location_count": 5, "location_summary": "Rochester, Minnesota • New York, New York • Cleveland, Ohio + 2 more", "locations": [ { "city": "Rochester", "state": "Minnesota" }, { "city": "New York", "state": "New York" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04474847" }, { "nct_id": "NCT02161406", "title": "A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diffuse Cutaneous Systemic Sclerosis" ], "interventions": [ { "name": "Abatacept", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dinesh Khanna, MD, MS", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 88, "start_date": "2014-09", "completion_date": "2018-10-17", "has_results": true, "last_update_posted_date": "2020-02-17", "last_synced_at": "2026-10-03T01:26:50.873Z", "location_count": 23, "location_summary": "Los Angeles, California • Redwood City, California • Washington D.C., District of Columbia + 17 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02161406" }, { "nct_id": "NCT00430677", "title": "Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Systemic Lupus Erythematosus" ], "interventions": [ { "name": "Corticosteroids (prednisone or prednisolone)", "type": "DRUG" }, { "name": "Abatacept", "type": "DRUG" }, { "name": "Mycophenolate mofetil (MMF)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 423, "start_date": "2007-06", "completion_date": "2011-08", "has_results": true, "last_update_posted_date": "2015-03-20", "last_synced_at": "2026-10-03T01:26:50.873Z", "location_count": 14, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Los Angeles, California + 11 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00430677" }, { "nct_id": "NCT04925375", "title": "Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Interstitial Lung Disease", "Common Variable Immunodeficiency" ], "interventions": [ { "name": "Abatacept", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": null, "sex": "ALL", "summary": "4 Years and older" }, "enrollment_count": 38, "start_date": "2021-07-14", "completion_date": "2028-07", "has_results": false, "last_update_posted_date": "2026-07-22", "last_synced_at": "2026-10-03T01:26:50.873Z", "location_count": 6, "location_summary": "San Francisco, California • Tampa, Florida • Burlington, Massachusetts + 3 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Burlington", "state": "Massachusetts" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04925375" }, { "nct_id": "NCT05335928", "title": "Abatacept in Immune Checkpoint Inhibitor Myocarditis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Myocarditis Acute", "Cancer" ], "interventions": [ { "name": "Abatacept plus", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 390, "start_date": "2022-07-02", "completion_date": "2029-10-09", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-10-03T01:26:50.873Z", "location_count": 29, "location_summary": "Los Angeles, California • Washington D.C., District of Columbia • Tampa, Florida + 21 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Tampa", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05335928" } ] }